Oral Anti-Hyperglycaemic Therapies Effective for Management of diabetes secondary to pancreatic condition: Study Dr Riya Dave13 Jan 2025 9:45 AM ISTOral anti-hyperglycaemic therapies improve the glycaemic control in type 3c diabetes individuals as a consequence of pancreatic diseases. A recent...
Intermittent Fasting Shows Promise for Weight loss and improved Metabolic Health in new research Medha Baranwal21 Dec 2024 9:00 AM ISTChina: A recent comprehensive umbrella review has emphasized the potential benefits of intermittent fasting (IF), particularly time-restricted eating...
Atrasentan Enhances Insulin Sensitivity in Type 2 Diabetes Patients with Chronic Kidney Disease: Study Reveals Medha Baranwal30 Nov 2024 9:00 AM ISTNetherlands: A recent study, published in Diabetes, Obesity and Metabolism has revealed that atrasentan, an endothelin receptor antagonist,...
Semaglutide Improves Sperm Quality and Testosterone Levels in Obese Men with Type 2 Diabetes and Hypogonadism: Study Medha Baranwal21 Nov 2024 8:45 AM ISTSlovenia: A recent study published in Diabetes, Obesity and Metabolism has revealed that semaglutide, a medication primarily used to treat type 2...
Combining SGLT2 Inhibitors and Pioglitazone May Reduce Risk of MASH in Type 2 Diabetes, Study Finds Medha Baranwal16 Nov 2024 8:15 AM ISTChina: A recent real-world study has revealed promising benefits from combining sodium-glucose co-transporter 2 inhibitors (SGLT2i) and pioglitazone...
Transforming Diabetes Management: Continuous Ketone Monitoring Offers New Hope for DKA Prevention, Study Medha Baranwal13 Nov 2024 8:45 AM ISTAustralia: In a recent study published in Diabetes, Obesity and Metabolism, the researchers present an innovative device that has the potential to be...
Oral Semaglutide Improves liver steatosis and injury in Diabetes Patients with MASLD, suggests study Jacinthlyn Sylvia29 Oct 2024 8:45 AM ISTA recent study highlights the potential benefits of oral semaglutide in managing type 2 diabetes mellitus (T2DM) for patients with metabolic...
Triple Therapy: GEMI + DAPA Enhances Glycemic Control for Type 2 Diabetics on Metformin, SOLUTION 2 study Medha Baranwal3 Oct 2024 8:00 AM ISTSouth Korea: Gemigliptin and dapagliflozin dual add-on therapy (GEMI+DAPA) along with metformin is safe, effective, and well-tolerated, particularly...
Ertugliflozin Lowers Uric Acid and Reduces Gout Risk in Type 2 Diabetes Patients with CVD, VERTIS CV Analysis Medha Baranwal24 Sept 2024 9:00 AM ISTCanada: Recent post hoc analyses from the VERTIS CV trial reveal promising results for ertugliflozin, a medication used to manage type 2 diabetes. The...
Dapagliflozin Enhances Glycemic Control When Added to Evogliptin and Metformin in Type 2 Diabetes Patients: Study Medha Baranwal13 Sept 2024 9:45 AM ISTKorea: A recent randomized, double-blind, placebo-controlled study has revealed promising results for adding dapagliflozin to an existing regimen of...
Longer Diabetes duration, Strict Glycemic Control Linked to Increased Fracture Risk at Specific Sites: Study Medha Baranwal12 Sept 2024 9:00 AM ISTNetherlands: A new study, published in Diabetes, Obesity and Metabolism sheds light on how various characteristics of type 2 diabetes (T2D) are...
DASH diet may decrease visceral, subcutaneous, and hepatic lipid levels in those with type 2 diabetes: Study Jacinthlyn Sylvia19 Aug 2024 9:30 AM ISTA new study published in the journal of Diabetes, Obesity and Metabolism found that adhering to the Dietary Approaches to Stop Hypertension (DASH)...
